JS Capital Management’s Repligen RGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
Sell
-2,500
Closed -$486K 95
2021
Q1
$486K Buy
+2,500
New +$513K 0.03% 82
2020
Q3
Sell
-7,600
Closed -$939K 209
2020
Q2
$939K Buy
+7,600
New +$894K 0.07% 40

Other funds holding RGEN

JS Capital Management's RGEN Position: Q2 2021 in Review

JS Capital Management sold out of Repligen (RGEN) in Q2 2021, closing a stake of 2,500 shares — an estimated $486K sold.

JS Capital Management first reported a position in RGEN in Q2 2020 and held it in 2 quarters. The position peaked at $939K in Q2 2020. 429 funds tracked by Wall St. Rank hold RGEN as of Q2 2021.

  • JS Capital Management reported no remaining Repligen position as of Q2 2021 after selling out during the quarter.
  • JS Capital Management sold 2,500 Repligen shares in Q2 2021, an estimated $486K.
  • JS Capital Management first reported a position in Repligen in Q2 2020 and held it in 2 quarters.
  • JS Capital Management's Repligen position peaked at $939K in Q2 2020.
  • 429 funds tracked by Wall St. Rank held Repligen as of Q2 2021.

Based on JS Capital Management's 13F filing for Q2 2021, filed 16 Aug 2021.